Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Biomedicines|November 11, 2022
Responsive Neurostimulation for Seizure Control: Current Status and Future DirectionsUjwal Boddeti, Darrian McAfee, Anas Khan, et al.
Frontiers in Network Physiology|August 22, 2024
Therapeutic approaches targeting seizure networksJenna Langbein, Ujwal Boddeti, Matthew Kreinbrink, et al.
Frontiers in Cellular Neuroscience|November 29, 2023
Differential metabolic alterations in IDH1 mutant vs. wildtype glioma cells promote epileptogenesis through distinctive mechanismsDarrian McAfee, Mitchell Moyer, Jaden Queen, et al.
Neuro-Oncology Advances|July 18, 2024
Differential gene expression underlying epileptogenicity in patients with gliomasArmin Mortazavi, Anas U Khan, Edwin Nieblas-Bedolla, et al.
Frontiers in Network Physiology|September 18, 2024
Modeling seizure networks in neuron-glia cultures using microelectrode arraysUjwal Boddeti, Jenna Langbein, Darrian McAfee, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|July 13, 2022
Fluconazole Is Neuroprotective via Interactions with the IGF-1 ReceptorValerie Toodle, Myoung-Hwa Lee, Muzna Bachani, et al.
AIDS (London, England)|December 3, 2019
Presence of Tat and transactivation response element in spinal fluid despite antiretroviral therapyLisa J Henderson, Tory P Johnson, Bryan R Smith, et al.
Neuro-Oncology|January 7, 2022
IDH-mutated gliomas promote epileptogenesis through d-2-hydroxyglutarate-dependent mTOR hyperactivationArmin Mortazavi, Islam Fayed, Muzna Bachani, et al.
Science Translational Medicine|October 2, 2015
Human endogenous retrovirus-K contributes to motor neuron diseaseWenxue Li, Myoung-Hwa Lee, Lisa Henderson, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 24, 2020
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitorsRachel P M Abrams, Adam Yasgar, Tadahisa Teramoto, et al.
Pageof 2